The Catholic University of Korea Industry-academic Cooperation Foundation

Lg Chem, Ltd

Lucas Bio Co. Ltd.

Mitoimmune Therapeutics Inc.

Seok Goo Cho

Nayoun Kim

Jung Yeon Lim

Keon-Il Im

Eun Jung Kim

Young-Sun Nam

Jung-Yeon Lim

Keon Il Im

Na Youn Kim

Young Sun Nam

Eun Joo Jeon

Eun Sol Lee

The present invention relates to a method for inducing and proliferating target virus antigen-specific dual activated T cells, and can produce target virus antigen-specific dual activated T cells by treating monocytes, which are isolated from peripheral blood, with a cytokine and a virus antigen peptide mixture and culturing the same.

Method for enrichment and expansion of virus antigen-specific T cells

The present invention relates to a composition for preventing or treating mucositis comprising NecroX. It was found that NecroX has effects of reducing the disease mortality rate by means of radiotherapy or chemotherapy in a NecroX administration group, protecting intestinal functions, inhibiting destruction of intestinal mucous membrane, and proliferating the cells present in intestines. NecroX may be used for a pharmaceutical composition for preventing or treating mucositis, an anti-cancer adjuvant, or a food composition.

Composition for preventing or treating mucositis comprising NecroX as effective ingredient

Provided is a pharmaceutical composition for preventing or treating B-cell lymphoma including IL-21 expressing mesenchymal stem cells, and a treating method using the same.

Composition for preventing or treating B-cell lymphoma comprising IL-21 expressing mesenchymal stem cells

The present invention relates to new medical use of (tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholine-4-yl)methyl-1H-indol-7-yl]amine, and more particularly, to a pharmaceutical composition containing the compound as an active ingredient, which is used for inhibiting an immune response, and/or for inducing differentiation into regulator T cells from undifferentiated T cells and/or promoting proliferation of regulator T cells.

Pharmaceutical composition for inhibiting immune response through inducing differentiation into regulator T cells and promoting proliferation of regulator T cells

Growing community of inventors

Seoul, South Korea

Seok Goo Cho